Haplotype study of the CYP4A11 gene and coronary artery disease in Han and Uygur populations in China

Gene

Volumn 512, Issue 2, 2013, Pages 510-516

  Fu, Zhenyan ^a   Yang, Hong ^a   Ma, Yitong ^a   Huang, Ding ^a   Xie, Xiang ^a   Zheng, Yingying ^a   Zhu, Qing ^a   Nakayama, Tomohiro ^b  

^a XINJIANG MEDICAL UNIVERSITY   (China)

^b NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Case control study; CYP4A11; Haplotype; Single nucleotide polymorphism

Indexed keywords

CREATININE; CYTOCHROME P450 4A11; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UREA;

ADULT; ALLELE; ARTICLE; CHINA; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENOTYPE; GLUCOSE BLOOD LEVEL; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; CORONARY ARTERY DISEASE; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84870371807     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.10.007     Document Type: Article

References (37)

1. Chu Z.M., Croft K.D., Kingsbury D.A., Falck J.R., Reddy K.M. Cytochrome P450 metabolites of arachidonic acid may be important mediators in angiotensin II-induced vasoconstriction in the rat mesentery in vivo. Clin. Sci. (Lond.) 2000, 98:277-282.
2. Damani S.B., Topol E.J. Emerging genomic applications in coronary artery disease. JACC Cardiovasc. Interv. 2011, 4:473-482.
3. Elbekai R.H., El-Kadi A.O. Cytochrome P450 enzymes: central players in cardiovascular health and disease. Pharmacol. Ther. 2006, 112:564-587.
4. Fava C., Montagnana M., Almgren P., Rosberg L., Lippi G. The V433M variant of the CYP4F2 is associated with ischemic stroke in male Swedes beyond its effect on blood pressure. Hypertension 2008, 52:373-380.
5. Fu Z., Nakayama T., Sato N., Izumi Y., Kasamaki Y. Haplotype-based case study of human CYP4A11 gene and cerebral infarction in Japanese subject. Endocrine 2008, 33:215-222.
6. Gainer J.V., Bellamine A., Dawson E.P., Womble K.E., Grant S.W. Functional variant of CYP4A11 20-hydroxyeicosatetraenoic acid synthase is associated with essential hypertension. Circulation 2005, 111:63-69.
7. Gross G.J., et al. Cytochrome P450 and arachidonic acid metabolites: role in myocardial ischemia/reperfusion injury revisited. Cardiovasc. Res. 2005, 68:18-25.
8. He B.X., Shi L., Qiu J., Tao L., Li R. A functional polymorphism in the CYP3A4 gene is associated with increased risk of coronary heart disease in the Chinese Han population. Basic Clin. Pharmacol. Toxicol. 2011, 108:208-213.
9. Hermann M., Hellermann J.P., Quitzau K., Hoffmann M.M., Gasser T. CYP4A11 polymorphism correlates with coronary endothelial dysfunction in patients with coronary artery disease-the ENCORE Trials. Atherosclerosis 2009, 207:476-479.
10. Herrington D.M. Cardiovascular genomics: outcomes and implications. Can. J. Cardiol. 2010, 26(Suppl. A):60A-63A.
11. Hill E., Fitzpatrick F., Murphy R.C. Biological activity and metabolism of 20-hydroxyeicosatetraenoic acid in the human platelet. Br. J. Pharmacol. 1992, 106:267-274.
12. Imig J.D., Pham B.T., LeBlanc E.A., Reddy K.M., Falck J.R. Cytochrome P450 and cyclooxygenase metabolites contribute to the endothelin-1 afferent arteriolar vasoconstrictor and calcium responses. Hypertension 2000, 35:307-312.
13. Kaur-Knudsen D., Nordestgaard B.G., Tybjaerg-Hansen A., Bojesen S.E. CYP1B1 genotype and risk of cardiovascular disease, pulmonary disease, and cancer in 50,000 individuals. Pharmacogenet. Genomics 2009, 19:685-694.
14. Laffer C.L., Gainer J.V., Waterman M.R., Capdevila J.H., Laniado-Schwartzman M. The T8590C polymorphism of CYP4A11 and 20-hydroxyeicosatetraenoic acid in essential hypertension. Hypertension 2008, 51:767-772.
15. Letonja M., Peterlin B., Bregar D., Petrovic D. Are the T/C polymorphism of the CYP17 gene and the tetranucleotide repeat (TTTA) polymorphism of the CYP19 gene genetic markers for premature coronary artery disease in Caucasians?. Folia Biol (Praha) 2005, 51:76-81.
16. Lino Cardenas C.L., Renault N., Farce A., Cauffiez C., Allorge D. Genetic polymorphism of CYP4A11 and CYP4A22 genes and in silico insights from comparative 3D modelling in a French population. Gene 2011, 487:10-20.
17. Manace L.C., Godiwala T.N., Babyatsky M.W. Genomics of cardiovascular disease. Mt. Sinai J. Med. 2009, 76:613-623.
18. Mayer B., Lieb W., Götz A., König I.R., Aherrahrou Z. Association of the T8590C polymorphism of CYP4A11 with hypertension in the MONICA Augsburg echocardiographic substudy. Hypertension 2005, 46:766-771.
19. Mayer B., Lieb W., Götz A., König I.R., Kauschen L.F. Association of a functional polymorphism in the CYP4A11 gene with systolic blood pressure in survivors of myocardial infarction. J. Hypertens. 2006, 24:1965-1970.
20. McGiff J.C., Quilley J. 20-Hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids and blood pressure. Curr. Opin. Nephrol. Hypertens. 2001, 10:231-237.
21. Munshi A., Sharma V., Kaul S., Rajeshwar K., Babu M.S. Association of the -344C/T aldosterone synthase (CYP11B2) gene variant with hypertension and stroke. J. Neurol. Sci. 2010, 296:34-38.
22. Munshi A., Sharma V., Kaul S., Al-Hazzani A., Alshatwi A.A. Association of 1347 G/A cytochrome P450 4F2 (CYP4F2) gene variant with hypertension and stroke. Mol. Biol. Rep. 2012, 39:1677-1682.
23. Muthalif M.M., Benter I.F., Karzoun N., Fatima S., Harper J. 20-Hydroxyeicosatetraenoic acid mediates calcium/calmodulin-dependent protein kinase II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:12701-12706.
24. Muthalif M.M., Karzoun N.A., Gaber L., Khandekar Z., Benter I.F. Angiotensin II-induced hypertension: contribution of Ras GTPase/Mitogen-activated protein kinase and cytochrome P450 metabolites. Hypertension 2000, 36:604-609.
25. Nakayama T., Soma M., Saito S., Honye J., Yajima J. Association of a novel single nucleotide polymorphism of the prostacyclin synthase gene with myocardial infarction. Am. Heart J. 2002, 143:797-801.
26. Nithipatikom K., Gross E.R., Endsley M.P., Moore J.M., Isbell M.A. Inhibition of cytochrome P450 omega-hydroxylase: a novel endogenous cardioprotective pathway. Circ. Res. 2004, 95:e65-e71.
27. Quigley R., Baum M., Reddy K.M., Griener J.C., Falck J.R. Effects of 20-HETE and 19(S)-HETE on rabbit proximal straight tubule volume transport. Am. J. Physiol. Renal Physiol. 2000, 278:949-953.
28. Rodenburg E.M., Visser L.E., Danser A.H., Hofman A., van Noord C. Genetic variance in CYP2C8 and increased risk of myocardial infarction. Pharmacogenet. Genomics 2010, 20:426-434.
29. Schwartzman M.L., Abraham N.G., Masferrer J., Dunn M.W., McGiff J.C. Cytochrome P450 dependent metabolism of arachidonic acid in bovine corneal epithelium. Biochem. Biophys. Res. Commun. 1985, 132:343-351.
30. Sofi F., Giusti B., Marcucci R., Gori A.M., Abbate R. Cytochrome P450 2C19*2 polymorphism and cardiovascular recurrences in patients taking clopidogrel: a meta-analysis. Pharmacogenomics J. 2011, 11:199-206.
31. Sugimoto K., Akasaka H., Katsuya T., Node K., Fujisawa T. A polymorphism regulates CYP4A11 transcriptional activity and is associated with hypertension in a Japanese population. Hypertension 2008, 52:1142-1148.
32. Uddin M.R., Muthalif M.M., Karzoun N.A., Benter I.F., Malik K.U. Cytochrome P-450 metabolites mediate norepinephrine-induced mitogenic signaling. Hypertension 1998, 31:242-247.
33. Vazquez B., Rios A., Escalante B. Arachidonic acid metabolism modulates vasopressin-induced renal vasoconstriction. Life Sci. 1995, 56:1455-1466.
34. Ward N.C., Tsai I.J., Barden A., van Bockxmeer F.M., Puddey I.B. A single nucleotide polymorphism in the CYP4F2 but not CYP4A11 gene is associated with increased 20-HETE excretion and blood pressure. Hypertension 2008, 51:1393-1398.
35. Williams J.S., Hopkins P.N., Jeunemaitre X., Brown N.J. CYP4A11 T8590C polymorphism, salt-sensitive hypertension, and renal blood flow. J. Hypertens. 2011, 29:1913-1918.
36. Zhang R., Lu J., Hu C., Wang C., Yu W. A common polymorphism of CYP4A11 is associated with blood pressure in a Chinese population. Hypertens. Res. 2011, 34:645-648.
37. Zordoky B.N., El-Kadi A.O. Effect of cytochrome P450 polymorphism on arachidonic acid metabolism and their impact on cardiovascular diseases. Pharmacol. Ther. 2010, 125:446-463.